IRUBIS | Innovative Process Analytical Spectroscopy for Biomanufacturing.
IRUBIS develops advanced Process Analytical Technology (PAT) tool based on mid-infrared (MIR) spectroscopy to bring intelligence to biopharmaceutical manufacturing. Its flagship product, Monipa, with single-use capabilities delivers inline, real-time concentration data for proteins, excipients, and nucleic acids—empowering faster decision-making, reducing batch loss, and simplifying bioprocess development and scale-up.
Read more about our products and innovations at www.irubis.com.
Company Details
- Employees
- 18
- Founded
- -
- Address
- Bayerstraße 85a, Munich,bavaria 80335,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- irubis.com
- Keywords
- FTIR, Process Analytical Technology, Single-Use, Inline Monitoring, Online Monitoring, Downstream Bioprocessing, Biopharma, Protein monitoring, DNA/RNA monitoring.
- HQ
- Munich, Bavaria
Irubis Questions
Irubis's website is irubis.com
Irubis's LinkedIn profile is https://de.linkedin.com/company/irubis
Irubis has
18 employees.
View email and phone details for 18
employees at Irubis.
Irubis's industry is
Biotechnology Research
Irubis's top competitors are
Crosspoint Therapeutics,
Biomatter,
Allogenetics,
Proto Axiom,
Bioprocess360 Partners,
Talus Bio,
Nadmed Ltd.,
Harmonia Healthcare,
Pittan,
Nygen Analytics.
Irubis's categories are Biotechnology Research
Irubis's founding year is 2017
